Acadia Pharmaceuticals Inc.
Acadia Pharmaceuticals Inc. (ACAD) — Form 144: Proposed sale of shares
About this filing
Acadia Pharmaceuticals Inc. (ACAD) filed Form 144 (proposed sale of shares) with the SEC on Aug 5, 2026. Form 144 is notice that an insider or affiliate plans to sell shares.
Key facts
- Seller
- Schneyer Mark C.
- Relationship
- Officer
- Shares to sell
- 5,849
- Market value
- $158,800.35
- Approximate sale date
- Aug 5, 2026
- Broker
- Piper Sandler & Co Inc
- Acquired
- Aug 5, 2026 · Stock Option Exercise
Rule 10b5-1 plan · adopted May 19, 2025
More ACAD filings
- 4
Filed Oct 30, 2026
- 8-K
Filed Oct 23, 2026
- 8-K
Filed Sep 24, 2026
- 8-K
Filed Sep 11, 2026
- 4
Filed Aug 7, 2026
- SC 13G
Filed Aug 7, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.